Publicacións en colaboración con investigadores/as de Nanjing Drum Tower Hospital (1)

2014

  1. The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-Mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial

    Clinical Cancer Research, Vol. 20, Núm. 7, pp. 2001-2010